Abstract:
Malus sieversii (Ledeb.) M. Roem., an ancestral species of cultivated apples worldwide, harbors extensive genetic variation and valuable stress-resistance traits, including tolerance to cold and drought and resistance to disease, making it an important resource for
M.
domestica Borkh. improvement and disease management. In this study, metabolomic profiling identified 1 803 differentially accumulated metabolites during pathogen infection, with strong enrichment in secondary metabolic pathways, particularly those associated with flavonoids and phenolic acids. The phenolic acid metabolite 4-hydroxyphenyllactic acid and the flavonoid metabolite luteolin accumulated rapidly during the early stage of infection (1–2 days), indicating potential involvement in the initial plant defense response. Plate inhibition assays showed that 0.63 μg/mL 4-hydroxyphenyllactic acid and luteolin significantly reduced the growth area of pathogenic fungi by 55.71% and 63.21%, respectively. Combined application further enhanced inhibition, with mixture ratios of 3:7 and 1:9 reducing colony growth area by 81.88% and 77.13%, respectively. Both compounds also significantly reduced lesion areas in
M. sieversii tissue-cultured seedlings and leaves of
M. domestica, and their combined application produced a synergistic protective effect. These findings identify 4-hydroxyphenyllactic acid and luteolin as active antifungal metabolites against apple canker pathogens and provide candidate bioactive compounds and optimized combination strategies for environmentally sustainable control of apple canker.